Sanskriti Thakur
About Sanskriti Thakur
Sanskriti Thakur is a prominent figure in the fields of health and technology, currently serving as the Chief Strategy Officer Community at the World Economic Forum and Chairwoman at TOWER Capital Group. With a strong background in pharmaceutical strategy and innovation, she has held leadership roles at various organizations and has published extensively on the intersections of science, health, and business.
Work at World Economic Forum
Sanskriti Thakur serves as a Global Future Council Member and Chief Strategy Officer Community at the World Economic Forum. She has held this position since 2020, contributing to discussions and initiatives that shape global health and business strategies. Her role involves collaborating with leaders across various sectors to address pressing global challenges and promote innovative solutions.
Education and Expertise
Sanskriti Thakur holds an MBA from NYU Stern School of Business, where she studied Strategy, Finance, and Global Business. Additionally, she earned a Bachelor of Science in Chemistry from Union College and completed graduate courses in Biotechnology at Columbia University. Her educational background equips her with a strong foundation in both business and scientific disciplines.
Professional Experience
Thakur has extensive experience in the pharmaceutical and life sciences sectors. She worked at Boehringer Ingelheim as Pharmaceutical Director, Strategy, Innovation & Operations from 2012 to 2014. Following this, she served as Principal Director and Global Life Science Research Lead at Accenture from 2015 to 2021. She also held the position of Chief Growth Officer at Medable, Inc. from 2021 to 2023, and acted as an Advisor to the CEO at the same company in 2023.
Achievements in Leadership
Sanskriti Thakur has played a significant role in leading pandemic disaster response efforts and has been instrumental in reframing the multi-trillion dollar category of Generational Health. Under her leadership, TOWER Capital Group has been recognized as a key partner by prominent organizations, including the World Economic Forum. She has also published over 18 research articles that explore the intersections of science, health, business, and technology.
Impact on Digital Health
Thakur has led a $2.3 billion growth-stage company that has made significant advancements in medicine, particularly in the digital health space. She is noted for being one of the first females in corporate venture capital for this sector, demonstrating her commitment to innovation and leadership in health technology.